Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Equity earnings (loss) in AmerisourceBergen

Impairment of goodwill

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Walgreens

Duane Reade is a subsidiary of Walgreens Boots Alliance, is a chain of pharmacy and convenience stores, primarily located in New York City, known for its high volume small store layouts in densely populated Manhattan locations.

Duane Reade

Boots UK is a pharmacy chain in the United Kingdom, Ireland, Norway, Thailand and other territories. Boots became a subsidiary of the new company, Walgreens Boots Alliance, on 31 December 2014.

Boots UK

Alliance Healthcare was formerly Alliance UniChem, wholesales, distributes, and retails pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres and hospitals from over 288 distribution centres in 11 countries. The company is a wholly owned subsidiary of Walgreens Boots Alliance, which was formed by the merger of Walgreens with its former parent Alliance Boots in 2014. Alliance Boots had itself been formed in 2006 by the merger of Boots Group and Alliance UniChem on 31 July 2006. Alliance UniChem was rebranded Alliance Healthcare in 2009.

Alliance Healthcare

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Walgreens reports Q1 earnings decline, eyes growth opportunities ahead

Walgreens faces challenges from COVID impacts and investments but is on track to achieve full-year guidance.
Strategic acquisitions and scaling U.S. Healthcare present opportunities for growth and profitability.
Despite first-half declines, the company anticipates improvements in margins and performance in the second half.
Efforts to optimize cash flow and investments position Walgreens for future growth and success.

Walgreens reports 4.5% sales growth in Q2 2023 earnings

Walgreens remains cautiously optimistic about managing potential changes in health plans and anticipates a strong second half of the year. The company is targeting debt reduction and small tuck-on acquisitions in healthcare as capital allocation priorities.

Walgreens (WBA) reports mixed Q3 performance, focuses on profitability

Walgreens (WBA) Q3 2023 earnings call highlights mixed performance with a focus on profitability enhancement.
Strategic partnerships, cost management programs, and capital allocation priorities support long-term value creation.
Challenges in margin pressures, script growth, and operational issues require immediate actions for profitability.
Opportunities lie in unlocking profitability, market developments, and demand for risk-based health care services.

Walgreens appoints new CEO to drive cost savings and script growth opportunities

Walgreens is strategically positioning itself for operational efficiency and cost savings in fiscal year 2024. The company's new CEO, Tim Wentworth, is expected to drive healthcare expertise and cost-effective outcomes. Despite challenges like lower contributions and segment declines, Walgreens is leveraging opportunities for script growth and financial improvement.

Walgreens Q1 Earnings: Navigating Challenges, Focused on Value Creation

Walgreens is navigating challenges in the pharmacy sector while focusing on strategic initiatives to drive value creation and sustainable growth. The company's emphasis on partnerships, cost-saving actions, and a shift towards value-based reimbursement models positions them for future success in the evolving healthcare landscape.

Walgreens reports solid Q2 results, focuses on growth strategies

Walgreens navigates retail challenges with strong operational performance. Focus on cost discipline, portfolio optimization, and cash flow improvement. Strategic decisions to drive growth and unlock value in healthcare areas.

Walgreens Q3 Earnings Miss Expectations Amid Challenges

Walgreens' Q3 2024 earnings call highlighted a challenging quarter with missed expectations, driven by pressures in the retail pharmacy sector and adverse market conditions. CEO Tim Wentworth emphasized ongoing strategic reviews and cost management initiatives as key to navigating these challenges. The company remains committed to transforming its business model to better serve customers and improve operational efficiency.

Walgreens (WBA) reports Q4 earnings, focuses on growth strategies

Walgreens (WBA) focused on financial stability, cost efficiency, and strategic growth initiatives in Q4 2024 earnings call.
The company aims to address challenges like disruptions, inflation, and underperforming stores while leveraging strengths in cash flow and cost-cutting.
Opportunities in store optimization, digital enhancement, and asset monetization are key areas for future growth.
Overall, Walgreens is navigating challenges, leveraging strengths, and pursuing opportunities to enhance financial performance and resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Despite almost a 40% decline in Walgreens Boots Alliance’s stock since the beginning of this year, at the current price of around $35 per share, we believe Walgreens has a significant upside. Why is that?

Walgreens Stock Looks Attractive At $35

Boeing

Chevron

Share prices of some blue chips have been pulled lower by the market-wide sell-off. Others are down for more fundamental reasons.

Is It Time to Buy These 3 Beaten-Down Dow Jones Stocks?

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance, Inc. will release its fourth quarter and fiscal 2020 earnings results at 7 a.m. Eastern time Thursday, Oct. 15.

Walgreens Boots Alliance Schedules Fourth Quarter and Fiscal 2020 Earnings Announcement for October 15, 2020

People's United Financial

AT&T

Exxon Mobil

If you're looking for the cream of the crop when it comes to yield, then dividend aristocrats are your friends. Here are five of the best.

The Top 5 Dividend Aristocrats for Total Returns

Credit Acceptance

Cisco Systems

F5 Networks

Kroger

These 5 oversold stocks present solid investment opportunities and could be set for a quick rebound in the coming months.

5 Oversold Stocks Ready for a Bounce

AbbVie

Intel

Micron Technology

Seagate Technology Holdings PLC

Teva Pharmaceutical

Western Digital

The stock market may have forgotten about these seven undervalued stocks, but you can pick them up now on the cheap. 
The post 7 Undervalued Stocks With Massive Potential appeared first on InvestorPlace.

7 Undervalued Stocks With Massive Potential

DEERFIELD, Ill.--(BUSINESS WIRE)--To further aid employers with creating a safe and protected work environment, Walgreens has launched Walgreens Test & Protect™, a new program to aid businesses in their COVID-19 work plans and strategies.

Walgreens Launches Walgreens Test & Protect Program™ to Aid Businesses’ COVID-19 Strategies

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance (Nasdaq: WBA) today released the company’s first global diversity and inclusion (D&I) report, while also announcing recent efforts aimed at addressing healthcare disparity in underserved communities.

Walgreens Boots Alliance Releases Global Diversity & Inclusion Report and Expands Support for Underserved Communities

Amcor Plc

Franklin Resources

The following 6 (as of 9/11/20) realized the ideal of offering annual dividends from a $1K investment exceeding their single share prices:(XOM, T, PBCT, BEN, WBA, & AMCR).

Dividend Aristocrats See 6 Star September Selections

Archer-Daniels-Midland Company

Bristol-Myers

Bank of Nova Scotia

Cardinal Health

CVS Health

Essex Property Trust

Federal Realty Investment Trust

General Dynamics

Merck

Realty Income Corp

Omnicom Group

Oracle

Pinnacle West Capital

Prudential Financial

Reinsurance Group of America

STORE Capital

When I posted my monthly update and noted my large increase in my cash position, from 4% to over 10%, some readers messaged/asked me how I intend to invest this.

I'm Investing $50,000 In These Dividend-Paying Companies

Altria

Philip Morris

Just as in the story of the tortoise and the hare, value investors likely believe that slow and steady will win the race.

8 Overlooked Companies That Keep Raising Dividends Ever Higher

Alexion Pharma

Wells Fargo

If getting a good deal is your thing, you're going to love these bargains.

Labor Day Special: 3 Deep-Discount Stocks to Buy Now

Walgreens reported an operating income loss of ($1,548M) in Q3 FY '20, with most business operations negatively impacted by COVID-19.

Walgreens: Will The Dividend Get The Boot?

Aflac

Con Ed

Be Safe From A Market Crash With These 5 Undervalued Low-Risk Dividend Aristocrats

Black Hills

Calgon Carbon

Community Trust Bancorp

Illinois Tool Works

National Fuel Gas

Northwest Natural Gas

Telephone and Data Systems

United Bankshares

Universal Corp

65 Reliable 40Yr+ Dividend Hikes Reported For September

Enterprise Products Partners

Mylan

Newell Brands

Ralph Lauren

Southern Company

It might seem odd on Main Street that the S&P 500 has managed to recapture all its losses after the panic selling seen in February and March.

11 Blue Chip Stocks That Refuse to Rally With the Market’s All-Time Highs

AbbVie, Cardinal Health, and Walgreens Boots Alliance are all showing growth, and each boasts a yield of at least 3.8%.

3 Ultra-High-Yield Medical Stocks That Aren't Done Growing Yet

But making Walgreens Boots Alliance an even more interesting and timely stock to look at, is the fact that in trading on Tuesday, shares of WBA entered into oversold territory, changing hands as low as $36.50 per share.

Walgreens Boots Alliance Becomes Oversold

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens today announced new offerings to support people with chronic and acute pain, including the launch of Walgreens brand diclofenac gel, an over-the-counter original prescription-strength arthritis pain relief in topical form.

Walgreens Introduces Owned Brand Arthritis Pain Relief Gel Alongside Personalized Pain Management Support

Walgreens Boots Alliance Monday named former Rite Aid CEO John Standley as president of Walgreens, saying he will lead all of the drugstore chain’s operations.

Walgreens Taps Former Rite Aid CEO Standley As President To Lead Operations

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance, Inc.

Walgreens Boots Alliance Appoints John Standley President of Walgreens

The 4 Best Dividend Aristocrats Retirees Can Buy With The Market At All-Time Highs

Apple

Tesla

As investors, there are always opportunities out there.

Dividend Stock Watch List: Lanny's September 2020 Edition

News for Walgreens Stock (WBA)